A possible role of acrolein in diabetic retinopathy: Involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia

Current Eye Research

Volumn 37, Issue 11, 2012, Pages 1045-1053

  Grigsby, Jeffery ^a   Betts, Brandi ^a   Vidro Kotchan, Eileen ^a   Culbert, Richard ^b   Tsin, Andrew ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b Texas Tech University Health Sciences Center at the Permian Basin   (United States)

Author keywords

Acrolein; Age related macular degeneration; NBHA; TGF ; VEGF and RPE

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACROLEIN; BENZOHYDROXAMIC ACID; GLUCOSE; SIS 3; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; HYPERGLYCEMIA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACROLEIN; CELL LINE; CELL SURVIVAL; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERGLYCEMIA; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866913833     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.713152     Document Type: Article

References (71)

1. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
2. Carmella SG, Chen M, Zhang Y et al. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography- atmospheric pressure chemical ionization tandem mass spectrom-etry: effects of cigarette smoking. Chem Res Toxicol 2007;20:986-990.
3. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999;9:109-113.
4. Pan J, Keffer J, Emami A et al. Acrolein-derived DNA adduct formation in human colon cancer cells: its role in apopto-sis induction by docosahexaenoic acid. Chem Res Toxicol 2009;22:798-806.
5. Bazan NG. Survival signaling in retinal pigment epithelial cells in response to oxidative stress: signifcance in retinal degenerations. Adv Exp Med Biol 2006;572:531-540.
6. Medina-Navarro R, Duran-Reyes G, Diaz-Flores M et al. Glucose-stimulated acrolein production from unsaturated fatty acids. Hum Exp Toxicol 2004;23:101-105.
7. O'Brien PJ, Siraki AG, Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 2005;35:609-662.
8. Uchida K, Kanematsu M, Morimitsu Y et al. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 1998;273:16058-16066.
9. Chung FL, Young R, Hecht SS. Formation of cyclic 1,N2- propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 1984;44:990-995.
10. LoPachin RM, Barber DS, Gavin T. Molecular mechanisms of the conjugated alpha,β-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 2008;104:235-249.
11. Komeima K, Rogers BS, Lu L et al. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 2006;103:11300-11305.
12. Yong PH, Zong H, Medina RJ et al. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Muller glia dysfunction and death in diabetic reti-nopathy. Mol Vis 2010;16:2524-2538.
13. Zhang X, Lai Y, McCance DR et al. Evaluation of N (epsilon)-(3-formyl-3, 4-dehydropiperidino)lysine as a novel bio-marker for the severity of diabetic retinopathy. Diabetologia 2008;51:1723-1730.
14. Vidro-Kotchan E. The reactive aldehyde, acrolein, and factors associated with proliferative retinopathy. Department of Biology, University of Texas at San Antonio, San Antonio, Texas, 2010.
15. Nicoletti R, Venza I, Ceci G et al. Vitreous polyamines sper-midine, putrescine, and spermine in human proliferative disorders of the retina. Br J Ophthalmol 2003;87:1038-1042.
16. Vogt RR, Unda R, Yeh LC et al. Bone morphogenetic pro-tein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem 2006;98:1196-1202.
17. Dawson DW, Volpert OV, Gillis P et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-248.
18. Pfeffer BA, Flanders KC, Guérin CJ et al. Transforming growth factor β 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res 1994;59:323-333.
19. Simó R, Villarroel M, Corraliza L et al. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010;2010:190724.
20. Stevens JF, Maier CS. Acrolein: sources, metabolism, and bio-molecular interactions relevant to human health and disease. Mol Nutr Food Res 2008;52:7-25.
21. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994;43:836-841.
22. Ellis EA, Grant MB, Murray FT et al. Increased NADH oxi-dase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 1998;24:111-120.
23. Suzuki D, Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med 1999;38:309-314.
24. Nishikawa T, Edelstein D, Du XL et al. Normalizing mito-chondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
25. Curtis TM, Hamilton R, Yong PH et al. Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2011;54:690-698.
26. Tsukahara H, Sekine K, Uchiyama M et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003;54:419-424.
27. Daimon M, Sugiyama K, Kameda W et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr J 2003;50:61-67.
28. Noiri E, Yamada S, Nakao A et al. Serum protein acrolein adducts: utility in detecting oxidant stress in hemodialysis patients and reversal using a vitamin E-bonded hemodia-lyzer. Free Radic Biol Med 2002;33:1651-1656.
29. Vidro-Kotchan E, Yendluri BB, Le-Thai T et al. NBHA reduces acrolein-induced changes in ARPE-19 cells: possible involvement of TGFβ. Curr Eye Res 2011;36:370-378.
30. Heimsath EG Jr, Unda R, Vidro E et al. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res 2006;31:1073-1080.
31. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986;83:2496-2500.
32. Grigsby JG, Parvathaneni K, Almanza MA et al. Effects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferation. J Ocul Pharmacol Ther 2011;27:225-233.
33. Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specifc inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression. Mol Pharmacol 2006;69:597-607.
34. Diaz FJ, Wigglesworth K, Eppig JJ. Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 2007;120:1330-1340.
35. Inman GJ, Nicolás FJ, Callahan JF et al. SB-431542 is a potent and specifc inhibitor of transforming growth factor-β super-family type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002;62:65-74.
36. Laping NJ, Grygielko E, Mathur A et al. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol Pharmacol 2002;62:58-64.
37. Woodruff TJ, Wells EM, Holt EW et al. Estimating risk from ambient concentrations of acrolein across the United States. Environ Health Perspect 2007;115:410-415.
38. Batista CK, Brito GA, Souza ML et al. A model of hemor-rhagic cystitis induced with acrolein in mice. Braz J Med Biol Res 2006;39:1475-1481.
39. Park YS, Taniguchi N. Acrolein induces infammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann N Y Acad Sci 2008;1126:185-189.
40. Saiki R, Nishimura K, Ishii I et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 2009;40:3356-3361.
41. Tomitori H, Usui T, Saeki N et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005;36:2609-2613.
42. Joshi-Barve S, Amancherla K, Patil M et al. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radic Biol Med 2009;47:47-54.
43. Sakata K, Kashiwagi K, Sharmin S et al. Increase in putres-cine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003;305:143-149.
44. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 2007;35:7497-7504.
45. Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007;85:3036-3040.
46. Williams TI, Lynn BC, Markesbery WR et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 2006;27:1094-1099.
47. Jia L, Liu Z, Sun L et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by ®-alpha-lipoic acid. Invest Ophthalmol Vis Sci 2007;48:339-348.
48. Liu Z, Sun L, Zhu L et al. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxida-tive stress and mitochondrial dysfunction. J Neurochem 2007;103:2690-2700.
49. Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther 2010;26:231-236.
50. Feng Z, Liu Z, Li X et al. α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem 2010;21:1222-1231.
51. Shen JK, Dong A, Hackett SF et al. Oxidative damage in age-related macular degeneration. Histol Histopathol 2007;22:1301-1308.
52. Wood PL, Khan MA, Moskal JR. The concept of "aldehyde load" in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line. Brain Res 2007;1145:150-156.
53. Wood PL, Khan MA, Kulow SR et al. Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines. Brain Res 2006;1095:190-199.
54. Yoshida M, Tomitori H, Machi Y et al. Acrolein toxicity: comparison with reactive oxygen species. Biochem Biophys Res Commun 2009;378:313-318.
55. Du XL, Edelstein D, Rossetti L et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hex-osamine pathway and induces plasminogen activator inhibi-tor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000;97:12222-12226.
56. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
57. Callahan JF, Burgess JL, Fornwald JA et al. Identifcation of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J Med Chem 2002;45:999-1001.
58. Inoue Y, Canaff L, Hendy GN et al. Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells. J Cell Biochem 2009;108:285-294.
59. Carlsson LM, Jacobson P, Walley A et al. ALK7 expression is specifc for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 2009;382:309-314.
60. Esser P, Heimann K, Bartz-schmidt KU et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-β-induced RPE cell apoptosis. Exp Eye Res 1997;65:365-378.
61. Kishi H, Kuroda E, Mishima HK et al. Role of TGF-β in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol Int 2001;25:1125-1129.
62. Mitsuhiro MR, Eguchi S, Yamashita H. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-β superfamily. Acta Ophthalmol Scand 2003;81:630-638.
63. Lee SC, Seong GJ, Kim SH et al. Synthesized TGF-β s in RPE regulates cellular proliferation. Korean J Ophthalmol 1999;13:16-24.
64. Parent RA, Paust DE, Schrimpf MK et al. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identifcation of urinary and fecal metabolites. Toxicol Sci 1998;43:110-120.
65. Palma S, Cornetta T, Padua L et al. Infuence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res 2007;633:1-12.
66. Crabb DW, Matsumoto M, Chang D et al. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004;63:49-63.
67. Choudhary S, Xiao T, Srivastava S et al. Toxicity and detoxifca-tion of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 2005;204:122-134.
68. Rees JN, Florang VR, Anderson DG et al. Lipid peroxida-tion products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chem Res Toxicol 2007;20:1536-1542.
69. Traverso N, Menini S, Odetti P et al. Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med 2002;32:350-359.
70. Betts BS, Parvathaneni K, Yendluri BB et al. Ginsenoside-Rb-1 induces ARPE-19 proliferation and reduces VEGF release. ISRN Ophthalmol 2011;2011:6.
71. Sigma-Aldrich. Material Safety Data Sheets. 2012. Available at: http://www.sigmaaldrich.com.